TORONTO, Oct. 13, 2021 /PRNewswire/ -- FSD Pharma
Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) ("FSD Pharma" or
the "Company"), a life sciences holding company dedicated to
building a portfolio of assets and biotech solutions, is pleased to
announce that Anthony Durkacz,
Interim CEO of FSD Pharma, and Dr. Lakshmi P. Kotra, CEO of FSD's
wholly-owned subsidiary Lucid Psycheceuticals, will participate in
the KCSA Psychedelics Investor Conference to be held at
VirtualInvestorConferences.com on October
13-14, 2021.
Mr. Durkacz and Dr. Kotra will present live on Wednesday, October 13th at
2:30 p.m. ET. Register to attend
here.
For more information about the conference, or to schedule a
one-on-one meeting with FSD's management team, please contact KCSA
Strategic Communications at FSDPharma@kcsa.com.
About Virtual Investor Conferences®
Virtual Investor
Conferences (VIC) is the leading proprietary investor conference
series that provides an interactive forum for publicly-traded
companies to meet and present directly with investors.
A real-time solution for investor engagement, Virtual Investor
Conferences is part of OTC Market Group's suite of investor
relations services specifically designed for more efficient
Investor Access. Replicating the look and feel of on-site
investor conferences, Virtual Investor Conferences combine
leading-edge conferencing and investor communications capabilities
with a comprehensive global investor audience network.
Learn more about VIC and its events at
www.virtualinvestorconferences.com.
About FSD Pharma
FSD Pharma is a life sciences holding
company dedicated to building a portfolio of diversified
therapeutic assets and innovative healthcare and biotech services.
Currently, FSD is actively pursuing potential acquisition targets
in the healthcare and biotech space to bring innovative treatments
to market to treat various mental health disorders and
neurodegenerative diseases.
Forward Looking Information
Certain statements included in this press release constitute
forward-looking information or statements (collectively,
"forward-looking statements"), including those identified by the
expressions "anticipate", "believe", "plan", "estimate", "expect",
"intend", "may", "should" and similar expressions to the extent
they relate to the Company or its management. The forward-looking
statements are not historical facts but reflect current
expectations regarding future results or events. This press release
contains forward looking statements, including but not limited to
statements regarding the terms and deliverables of the various
agreements. These forward-looking statements are based on current
expectations and various estimates, factors and assumptions and
involve known and unknown risks, uncertainties, and other
factors.
Source: FSD Pharma Inc.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/fsd-pharma-to-present-at-the-kcsa-psychedelics-virtual-investor-conference-on-october-13th-301399091.html
SOURCE VirtualInvestorConferences.com